Quotient Sciences Acquires Arcinova

Read the press release here

White Papers

The development of medicines for Expanded Access or Compassionate Use in the treatment of serious diseases with no approved treatment – COVID-19

The development of medicines for Expanded Access or Compassionate Use in the treatment of serious diseases with no approved treatment – COVID-19 The World Health Organiz

Optimize your ADME/hAME study to overcome barriers and avoid delays for drug development success

The Optimize your ADMA/hAME study to overcome barriers and avoid delays for drug development success Optimization of human absorption, metabolism, and excretion (hAME) stu

Parenteral Dosage Form Development: Technical Challenges and Regulatory Requirements

Parenteral dosage forms account for approximately 40% of new drug product approvals. This paper summarises the various types of parenteral dosage forms routinely encountered in drug development an